Business
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot ...
About this update from Modular Medical, Inc.
[{"type":"text","content":"Targeting Q1 2026 Launch, Subject to FDA Clearance","length":50,"tagName":"p"},{"type":"text","content":"Key Highlights:","length":15,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production.","length":145,"tagName":"p"}]},{"val":[{"type":"text","content":"First Removable Tubeless Patch Pump: Pivot targets underserved "almost-pumpers" - adults with diabetes hesitant to move from multiple daily injections (MDI) due to cost and complexity - representing a significant portion of the growing ~$8 billion global insulin pump market.","length":285,"tagName":"p"}]},{"val":[{"type":"text","content":"Affordable, User-Friendly Design: A full 3ml removable cartridge and pump with a simple interface expands access for millions managing diabetes with MDI by providing significant clinical therapy improvement","length":206,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":636,"olType":false},{"type":"text","content":"SAN DIEGO, CA / ACCESS Newswire / February 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced the start of production of validation lots for its Pivot™ tubeless patch pump's disposable cartridge and infusion set. Achievement of this critical manufacturing milestone keeps the Company on schedule for commercial launch in Q1 2026, subject to receipt of FDA 510(k) clearance.","length":497,"tagName":"p"},{"type":"text","content":"The Pivot system - the industry's first removable, tubeless 3ml patch pump - is designed for simplicity and affordability, addressing barriers that prevent many patients from adopting traditional pumps.","length":206,"tagName":"p"},{"type":"text","content":"Transforming Access to Insulin Pump Therapy","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Targets almost-pumpers: Millions of adults relying on MDI who avoid pumps due to high cost and complexity.","length":106,"tagName":"p"}]},{"val":[{"type":"text","content":"Scalable, low-cost manufacturing platform positions the Company to capture significant share in the rapidly expanding diabetes tech sector.","length":139,"...